Skip to content

To compare different doses of dexmedetomidine for caudal anesthesia in children

To compare the different doses of dexmedetomidine for caudal anaesthesia in paediatric patients - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064168
Enrollment
105
Registered
2024-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: caudal analgesia: comparison of three different doses of adjuvant added to 0.25% bupivacaine to measure the duration of analgesia Control Intervention1: three different doses of Dexmede

Sponsors

Sri Guru Ram Das Institute of Medical Sciences and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society of Anaesthesiologists Physical Status I and II 2. Children where single shot caudal epidural is planned for post operative analgesia will be included in the study

Exclusion criteria

Exclusion criteria: 1. Local infection in the caudal region 2. Preterm neonate. 3. Preexisting neuromuscular disease 4. Sacral/vertebral abnormalities 5. Congenital anomaly. (Include specifically sacral anomalies/vertebral abnormalities, meningomyelocele, spina bifida, cauda equina) 6. Bleeding diathesis.

Design outcomes

Primary

MeasureTime frame
duration of postoperative analgesiaTimepoint: 5 min intervals at the time of caudal delivery of drug till 2 hours in PACU, then every 2 hours till 24 hours postoperatively

Secondary

MeasureTime frame
1) Incidence of bradycardia. 2) Incidence and severity of Post operative sedation and agitation. 3) Incidence of other side effectsTimepoint: at 30 min interval till 2 hours in PACU

Countries

India

Contacts

Public ContactDr Yashi Gautam

Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar

drruchisgrd@gmail.com9814020805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026